PathoGene exceeds initial financing goal and launches molecular diagnostics company

August 18, 2010

By hammersmith

[Source: Pathogene] – PathoGene, LLC – a molecular diagnostics company located in Northern Arizona – has completed its first round of financing and raised 150% of its stated goal of $500K in seed money for a total of $750K. This new venture is being championed by top tier scientists, successful laboratory managers and experienced biotech executives who are using licensed technology from Northern Arizona University (NAU) and The Translational Genomics Research Institute (TGen) as a launching pad for building a successful bioscience business. During the financing period (April-July, 2010) Todd Snowden, President of PathoGene, was a featured speaker at the Southwest Bioscience Expo in Tucson, Arizona where he presented the business case for investing in PathoGene.

For more information: PathoGene Exceeds Initial Financing Goal and Launches Molecular Diagnostics Company